Endpoints News 6 mars 2026 Pfizer gets obesity drug approval in China shortly after buying local rights
Endpoints News 24 févr. 2026 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News 7 févr. 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News 3 févr. 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 3 févr. 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News 8 janv. 2026 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News 5 déc. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News 4 déc. 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen